tradingkey.logo
tradingkey.logo
Search

iRhythm Technologies Inc

IRTC
Add to Watchlist
127.840USD
-0.280-0.22%
Close 08-07 16:00ETQuotes delayed by 15 min
4.13BMarket Cap
LossP/E TTM

Forecast

Currency: USD Updated: 2026-08-07
Previous score
9.07
Change
0
The current earnings forecast score of iRhythm Technologies Inc is 9.07, ranking 6 out of 200 in the Healthcare Equipment & Supplies industry. The average price target is 220.00, with a high of 244.00 and a low of 194.00.

Analyst Rating

Based on 15 analysts
Strong Buy
Current Rating
177.000
Target Price
+38.15%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

88
Total
4
Median
7
Average
Company name
Ratings
Analysts
iRhythm Technologies Inc
IRTC
15
Intuitive Surgical Inc
ISRG
34
Boston Scientific Corp
BSX
34
Thermo Fisher Scientific Inc
TMO
32
Edwards Lifesciences Corp
EW
32
Veeva Systems Inc
VEEV
30
1
2
3
...
18

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

FAQs

What is iRhythm Technologies Inc's expected revenue for the next quarter?

iRhythm Technologies Inc's expected revenue is 221.96M.

What is iRhythm Technologies Inc's price target?

Analysts forecast that iRhythm Technologies Inc's price target is USD 220.00, with the highest forecast at USD 244.00 and the lowest forecast at USD 194.00.

How have iRhythm Technologies IncIRTC's recent earnings per share performed?

The market expectation was USD -0.01, while iRhythm Technologies IncIRTC's earnings per share (EPS) for the previous quarter was USD -0.43. EPS for the next quarter is expected at USD 0.06.

What is the analyst rating for iRhythm Technologies Inc?

Based on the ratings of iRhythm Technologies Inc's stock from 15 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.